This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Cellvax, Centre National De La Recherche Scientifique, Institut Gustave Roussy. Active years: 2021-2026.
Company Filing History:
2 out of 2 
2 out of 5,383 
2 out of 101 
Years Active: 2021-2026
Title: Rami Mustapha: Innovator in Antibody Research
Introduction
Rami Mustapha is a notable inventor based in Lille, France. He has made significant contributions to the field of antibody research, particularly in the context of cancer treatment. With a total of 2 patents, his work focuses on innovative solutions to combat diseases associated with regulatory T lymphocytes.
Latest Patents
Rami Mustapha's latest patents include an antibody that is directed against galectin-9. This antibody serves as an inhibitor of the suppressor activity of regulatory T lymphocytes. The invention relates to the use of this antibody for the treatment of diseases linked to the suppressor activity of regulatory T lymphocytes, especially in cancer therapy.
Career Highlights
Throughout his career, Rami Mustapha has been associated with prestigious institutions such as Université de Lille and the Centre National de la Recherche Scientifique. His work has been instrumental in advancing the understanding of immune responses and therapeutic interventions.
Collaborations
Rami has collaborated with notable colleagues, including Nadira Delhem and Pierre Busson. Their combined expertise has contributed to the success of various research initiatives.
Conclusion
Rami Mustapha's innovative work in antibody research highlights his commitment to advancing medical science. His contributions are paving the way for new treatments in the fight against cancer.